Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Baricitinib shows promise in treating severe hair loss.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Oral baricitinib is effective and safe for treating alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Gefitinib can cause hair and eyebrow darkening.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Jujube fruit extract may reduce kidney damage from ibuprofen in rats.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.